Dawnrays Pharmaceutical Receives Approval for Trelagliptin Succinate Tablets for Type 2 Diabetes Treatment in China 1
Dawnrays Pharmaceutical Announces Key Product Approval: Trel...
Sign in to continue:
Dawnrays Pharmaceutical Announces Key Product Approval: Trel...
Dalipal Holdings Secures Major PetroChina Contract – Investo...
Jiangsu Guofu Hydrogen Energy - Major Overseas Business Upda...
3D Medicines Inc. Phase III Study Results and ASCO Presentat...
Impro Precision Industries Announces HKD546 Million Equity P...
KWG Group Announces Major Transaction – Disposal of JV Inter...
Numans Health Food Holdings Announces Possible Major Disposa...
UISEE Technologies Announces Major Expansion of Autonomous D...
Shenzhen SDMC Technology Co., Ltd. Global Offering Detailed ...
Shenzhen SDMC Technology Co., Ltd. - Key Details of Global O...